NEW YORK, July 1, 2021 / PRNewswire-PRWeb / – Ophthalmologists have many innovative new options to offer their patients for cataract surgery or vision correction options such as refractive lens exchange. Laser cataract removal makes cataract surgery more precise, more predictable, and better than ever. Many surgeons now also offer high-end IOLs, such as Panoptix IOLs or toric IOLs, which can allow patients undergoing cataract removal to see at all distances, even up close without glasses.
Leonard Bley, MD of the NY LAISK Laser & Microsurgery Center has been a leader in cataract surgery, surgery, LASIK and lens replacement in New York City for more than two decades. He was recently selected by RxSight ™ to be one of the few surgeons in the country and the first surgeon with offices in Manhattan, Brooklyn and Queens, to have Light-Adjustable Lens (LAL) technology to offer to its patients. This technology will be available to his patients as soon as June 23, 2021.
The light-adjustable lens (LAL) manufactured by RxSight ™ has multiple applications, including for people undergoing cataract ablation and those over the age of 40 starting to suffer from a condition called dysfunctional lens syndrome ( DLS). DLS is a term used by ophthalmologists to describe lens failure, the last stage being full-blown cataract. DLS causes patients to lose their near vision (usually after the age of 40) or problems with nighttime glare and / or halo.
Dysfunctional lens syndrome (DLS) is classified into three stages, which facilitates patient education.
Stage 1: 40-50 years
- Lens starts to stiffen, loses focusing power
- Loss of near vision
- Development of night-time glare or halos
Stage 2: 50 years and over
- Loss of accommodation, which results in complete loss of near vision and the need for reading glasses and / or bifocal glasses
- Vision-degrading light scattering formation, especially when driving at night
- Decreased contrast and night vision problems often resulting in glare and halos
Stage 3: 65 years and over
- Complete cataract
- Poor visual quality
- The nucleus of the lens turns yellow or becomes opaque, affecting color perception
- Major glare and halos at night
- Glasses no longer help improve vision
The lightweight adjustable lens (LAL) technology introduced by RxSight ™ is the first and only intraocular lens (IOL) that allows eye surgeons to make adjustments after cataract surgery. This can allow patients to have the best possible corrected vision for distance in their dominant eye and if they wish to be independent from reading glasses, the surgeon can adjust their non-dominant eye for reading vision.
The LAL is a three-part silicone lens that is implanted like a monofocal lens implant, except that the LAL is made with a special photoreactive silicone, allowing surgeons to adjust a patient’s prescription after implantation using specialized ultraviolet (UV) light. or light delivery device (LDD). This technology is also ideal for patients undergoing cataract surgery or refractive lens exchange due to Dysfunctional Lens Syndrome (DLS) who have had previous vision correction surgery such as LASIK, PRK or RK which are looking for a monovision or a more precise visual result after their cataract surgery.
In an FDA study that included 600 patients, those who received the LAL lens were twice as likely to achieve 20/20 vision without glasses, compared to those who received a standard monofocal lens.
Cataracts occur when the natural lens of the eye becomes cloudy and stiff, blurring and darkening vision. The only treatment option for cataracts is to remove the cloudy lens and replace it with an artificial lens implant. While cataracts are one of the leading causes of blindness, cataract removal is one of the safest and most common surgical procedures in the world. Lightweight adjustable lens technology in cataract surgery helps improve visual outcomes by allowing surgeons to completely fine-tune and customize the patient’s refractive outcome after cataract removal and LAL lens implantation.
“We are very happy to be chosen as the first firm with locations in Manhattan, Brooklyn and Queens to offer ALL technology to patients seeking the best possible visual outcome. We will also be treating patients from all over New York and beyond with this incredible technology, ”said Leonard Bley, MD-Medical Director at NY LASIK.
Dr. Robert grubbs of California Institute won the Nobel Prize in Chemistry in 2005 for its theory of olefin metathesis, which is used in LAL technology.
Ideal candidates for lightweight adjustable lens implants are patients concerned about their best possible distance vision, patients wanting monovision, or patients with a history of corneal surgery including LASIK, PRK or RK for irregular corneas. .
About Leonard Bley, MD and NY LASIK Laser and Institute of Microsurgery
Dr. Bley, founder of the Laser and Microsurgery Institute and the NY Lasik Center, is internationally recognized as a leader in the fields of cataract surgery and refractive surgery. He is one of a very select group of surgeons offering LASIK vision correction as well as LASIK alternatives such as implantation of intraocular contact lenses and removal of clear lenses. Dr. Bley is one of the pioneers of LASIK laser vision correction: he has been involved in refractive surgery field studies since 1989, before LASIK was officially approved by the FDA.
Dr. Bley has personally performed over 20,000 cataract and refraction procedures. He is one of a handful of selected surgeons across the country who perform laser cataract surgery as well as implantation of premium intraocular lenses. These lenses reduce or eliminate the need for reading glasses after cataract surgery, allowing the patient to significantly reduce their dependence on glasses. The new cataract laser system allows a level of precision previously inaccessible to cataract surgeons.
Paul Stubenbordt, Denali Creative – A Stubenbordt Company, +1 6828310900 Ext: 105, [email protected]
SOURCE NY LASIK